Meredith McCann

Associate

Admitted to the Ontario Bar: 2019

Print Bio

Instructions: Select the fields that you wish to include in the pdf generation.


% size of the Font for Generated PDF (Default is 80%)


 

  • Bio
  • Professional Involvement
  • Representative Matters
  • Selected Publications
  • Insights
  • Education

Meredith enjoys the fast-paced and challenging nature of securities law. When it comes to complex capital markets transactions or navigating regulatory requirements, Meredith is a relentless advocate for her clients’ interests. She is dedicated to providing exceptional service, and goes the extra mile to ensure her clients’ business objectives are met.

Meredith is a member of the firm’s Capital Markets Group. Her practice focuses on corporate finance, securities law, mergers and acquisitions and general corporate and commercial matters. She also has experience assisting clients in meeting continuous disclosure requirements and corporate governance matters.

Professional Involvement

Memberships:

  • Canadian Bar Association
  • Ontario Bar Association

Representative Matters

Represented Greenway Greenhouse Cannabis Corporation (CSE: GWAY) (OTC: GWAYF) in the completion of its placement of secured convertible debentures.

Represented Spectra7 Microsystems Inc. (TSXV: SEV) in the completion of its placement of convertible debentures.

Represented BZAM, a leading Canadian cannabis producer, in the acquisition of Final Bell Canada, an end-to-end supply chain system for cannabis brands, from Final Bell Holdings International.

Represented Cybin Inc. (NEO:CYBN) (NYSE American: CYBN), a life sciences company focused on psychedelic pharmaceutical therapies, in the completion of its US$30 million underwritten public offering of units.

Represented the agent in connection with the brokered private placement of units, each unit comprised of one common share and one-half of one common share purchase warrant, of a Nevada-based gold-mining company.

Represented Melchior Management 777 Corporation, a property management service company, with the formation of M Commercial REIT, a new private commercial real estate investment trust, and the related vend-in of a portfolio of commercial properties located in Barrie, Ontario.

Represented Cybin Inc. (NEO:CYBN) (NYSE American: CYBN), a life sciences company focused on psychedelic pharmaceutical therapies, in the launch of its US$35-million at-the-market equity program. 

Represented Cybin Inc. (NEO:CYBN) (NYSE American: CYBN), a life sciences company focused on psychedelic pharmaceutical therapies, in the completion of its US$8.25-million overnight marketed public offering of units.

Represented Cybin Inc., a life sciences company focused on psychedelic pharmaceutical therapies, in the completion of a US$30-million common share purchase agreement.

Advised Terminus Capital Partners, an Atlanta-based private equity firm, in its acquisition of actionable insights software platform, Voxco. 

Legal counsel to MediPharm Labs Corp. (TSX:LABS) in its acquisition of VIVO Cannabis Inc. 

Represented The Green Organic Dutchman Holdings Ltd. (CSE:TGOD) in the completion of a marketed public offering of units.

Advised Celestial Acquisition Corp. (TSXV:CES.P), a space technology-focused CPC , on its initial public offering on the TSX Venture Exchange. Celestial is the first space technology capital pool company to be listed on the TSX Venture Exchange.

Represented Jade Power Trust (TSXV:JPWR.UN) in connection with the sale of all its renewable energy assets located in Romania to Enery Power Holding GmbH for aggregate proceeds of €71 million ($98 million).

Advised The Green Organic Dutchman Holdings Ltd. (CSE:TGOD), a sustainable Canadian cannabis company and producer of premium, organically grown cannabis, in completing the acquisition of BZAM Holdings Inc., a privately-owned producer of flower and 2.0 products.

Represented Aleafia Health Inc., a vertically integrated and federally licensed Canadian cannabis company, in connection with the closing of its amendment of its $37 million convertible debentures and a private placement of units. 

Represented Allied Properties Real Estate Investment Trust, a leading operator of distinctive urban workspace in Canada’s major cities and network-dense urban data centres in Toronto, in its acquisition of six urban office properties from Choice Properties Real Estate Investment Trust for $794 million.

Represented Harborside Inc. (CSE: HBOR) (OTCQX: HBORF), a California-focused, vertically-integrated cannabis enterprise, in its acquisitions of Loudpack and Urbn Leaf.

Represented: SPARQ Systems Inc., a solar energy solutions company, and MJ Innovation Capital Corp. (TSXV:MSMJ.P), a capital pool company, in connection with SPARQ’s reverse takeover and qualifying transaction on the TSX Venture Exchange and concurrent financing of $10 million.  The resulting issuer started trading on January 7, 2022 under the name of SPARQ Corp. and the symbol TSXV:SPRQ.

Represented Nextleaf Solutions Ltd., a federally regulated producer of cannabis oil that distributes cannabis vapes and oils under its prohibition-era brand, Glacial GoldTM, in the completion of a marketed public offering of units.

Represented Cybin Inc., a biotechnology company focused on progressing psychedelic therapeutics, in the completion of an overnight marketed offering pursuant to a prospectus supplement to Cybin's short form base shelf prospectus, with aggregate gross proceeds of approximately $34 million.

Represented Baylin Technologies Inc. (TSX:BYL), a leading, diversified, global technology company, in its completion of a private placement offering of 17,648,000 common shares at a price of $0.85 per common share for aggregate gross proceeds of approximately $15 million.

Represented Greenway Greenhouse Cannabis Corporation in connection with its listing on the Canadian Securities Exchange under the symbol “GWAY”. 

Represented Haywood Securities Inc. and a syndicate of agents in connection with the $10.1 million subscription receipt financing of MineHub Technologies Inc. and related go-public transaction on the TSX Venture Exchange.  

Represented Allied Properties Real Estate Investment Trust, a leading owner, manager and developer of distinctive urban workspace in Canada’s major cities and network-dense urban data centres in Toronto, in its completion of a $500 million debt offering of 3.095% series I senior unsecured debentures. The Series I Debentures are Allied’s second Green Bond issuance under its previously announced Green Financing Framework.

Represented EQ Inc., a leader in geospatial data and artificial intelligence driven software, in its acquisition of the shares of Integrated Rewards Inc., and its consumer-facing application Paymi.com.

Advised Melchior Management 777 Corporation in the formation of a new private residential REIT consisting of 38 multi-family properties totalling 1,260 residential units located throughout southern Ontario. 

Advised MediPharm Labs Corp., a leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, in the completion of a $33 million bought deal offering.

Represented PsyBio Therapeutics, Inc., a biotechnology company developing a new class of drugs intended for the potential treatment of mental health challenges and other disorders, in the completion of its reverse takeover of PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) (TSXV:PSYB) and related private placement offering of subscription receipts for aggregate gross proceeds of $14.5 million.

Represented EQ Inc., in the completion of its overnight marketed offering of an aggregate of 7,187,500 common shares in the capital of the Company at a price of $1.60 per Offered Security for total gross proceeds of $11.5 million.

Represented Harborside Inc., a California-focused, vertically-integrated cannabis enterprise, in the completion of a brokered private placement offering of units for aggregate gross proceeds of approximately $35 million. 

Represented Allied Properties Real Estate Investment Trust in its completion of a $600 million debt offering of 1.726% series H senior unsecured debentures. The Series H Debentures are Allied’s inaugural Green Bond issuance under its recently announced Green Financing Framework.

Represented Cybin Inc., a biotechnology company focused on progressing psychedelic therapeutics, in the completion of a bought deal short form prospectus offering of units for aggregate gross proceeds of approximately $34 million.

Represented Cybin Inc. (the “Company”) (NEO: CYBN) in the completion of its reverse takeover of Clarmin Explorations Inc. pursuant to the terms of an amalgamation agreement among Cybin Corp., Clarmin and a wholly-owned subsidiary of the Company as well as a private placement offering of 60 million subscription receipts for aggregate gross proceeds of $45 million.

Represented Baylin Technologies Inc. (TSX:BYL), a leading, diversified, global technology company, in its completion of a private placement offering of 6,666,700 units at a price of $0.75 per unit.

Represented Energy+ Inc. in the closing of a $55 million offering of 2.968% senior unsecured debentures due August 10, 2060. The debentures were sold on an agency basis to accredited investors on a private placement basis by means of a confidential offering memorandum.

Represented MediPharm Labs Corp., a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, in its completion of a $37.8 million private placement with an institutional investor.

Represented Allied Properties Real Estate Investment Trust in its completion of a $300 million debt offering.

Represented Allied Properties Real Estate Investment Trust in its completion of a $400 million debt offering.

Represented Allied Properties Real Estate Investment Trust in its completion of a $345 million public equity offering of units.

Represented Pistil Partners Inc. in the completion of a private placement of its common shares and acquisition of Ironside Hemp Company Inc., a private U.S.-based hemp management company.

Represented MediPharm Labs Inc., a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, in the completion of a $75 million bought deal offering.

Selected Publications

"Rethinking Diversity in Canada’s Capital Markets: Beyond Gender," co-authored with Amy Marcen-Gaudaur and Melanie Cole, Aird & Berlis LLP Capital Markets Bulletin, November 2021.

"Modernizing Ontario’s Capital Markets: Capital Markets Act (Ontario)," co-authored with Melanie Cole, Capital Markets Bulletin, November 2021.

Education

  • JD, University of Windsor, 2018
  • LLB (Exchange Program), University of Lucerne, 2017
  • BA (Honours), Ryerson University, 2015